These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2112473)

  • 21. Adjuvant chemotherapy of recurrent superficial transitional cell carcinoma: results of a European organization for research on treatment of cancer randomized trial comparing intravesical instillation of thiotepa, doxorubicin and cisplatin. The European Organization for Research on Treatment of Cancer Genitourinary Group.
    Bouffioux C; Denis L; Oosterlinck W; Viggiano G; Vergison B; Keuppens F; De Pauw M; Sylvester R; Cheuvart B
    J Urol; 1992 Aug; 148(2 Pt 1):297-301. PubMed ID: 1635122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of superficial transitional cell bladder carcinoma. Long-term results of trial comparing transurethral resection alone and adjuvant chemotherapy with Doxorubicin].
    Milonas D; Mickevicius J; Mickevicius R; Motiejūnas A; Sukys D; Gudinaviciene I
    Medicina (Kaunas); 2002; 38 Suppl 1():79-83. PubMed ID: 12556642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of intravesical thiotepa on tumour recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer. A further report with long-term follow-up of a Medical Research Council randomized trial. Medical Research Council Working Party on Urological Cancer, Subgroup on Superficial Bladder Cancer.
    Br J Urol; 1994 Jun; 73(6):632-8. PubMed ID: 8032829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transurethral resection with perioperative instilation on interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer: a prospective randomized multicenter study--Finnbladder III.
    Rajala P; Liukkonen T; Raitanen M; Rintala E; Kaasinen E; Helle M; Lukkarinen O
    J Urol; 1999 Apr; 161(4):1133-5; discussion 1135-6. PubMed ID: 10081854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoprophylaxis of bladder cancer recurrence: immunological aspects.
    Corrado F; Lalanne G; Pizza GC
    Panminerva Med; 1975; 17(7-8):253-8. PubMed ID: 808781
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term observation after intravesical metaphylaxis with mitomycin C in patients with superficial bladder tumors.
    Maier U; Höbarth K
    Urology; 1991 May; 37(5):481-2. PubMed ID: 1902606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: a combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function.
    Hinotsu S; Akaza H; Ohashi Y; Kotake T
    Cancer; 1999 Nov; 86(9):1818-26. PubMed ID: 10547556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytostatic intravesical instillation in patients with superficial bladder carcinoma for the prevention of recurrent tumors.
    Huland H; Klöppel G; Otto U; Feddersen I; Brachmann W; Hubmann H; Kaufmann J; Knipper W; Lantzius-Beninga F
    Eur Urol; 1988; 14(3):202-6. PubMed ID: 3133216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of thiotepa and doxorubicin instillation at time of transurethral surgical treatment of bladder cancer on tumor recurrence: a prospective, randomized, double-blind, controlled trial.
    Zincke H; Utz DC; Taylor WF; Myers RP; Leary FJ
    J Urol; 1983 Mar; 129(3):505-9. PubMed ID: 6403716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Superficial bladder tumors. Preliminary results of a prospective study comparing endovesical BCG, adriamycin and thio-tepa].
    Martínez-Piñeiro JA; de la Peña J; Hidalgo L; Cisneros J; Jiménez León J; Machuca J; Perdices C
    Arch Esp Urol; 1985; 38(6):545-53. PubMed ID: 3938633
    [No Abstract]   [Full Text] [Related]  

  • 32. A trial of prophylactic thiotepa or mitomycin C intravesical therapy in patients with recurrent or multiple superficial bladder cancers.
    Flanigan RC; Ellison MF; Butler KM; Gomella LG; McRoberts JW
    J Urol; 1986 Jul; 136(1):35-7. PubMed ID: 3086575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative study of 3 series of patients treated respectively with thiotepa, adriamycin and cisplatin].
    Nogueira March JL; Ojea A; Jamardo D; Figueiredo L
    Actas Urol Esp; 1984; 8(4):325-8. PubMed ID: 6435407
    [No Abstract]   [Full Text] [Related]  

  • 34. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study.
    Martinez-Pineiro JA; Jimenez León J; Martinez-Pineiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
    Prog Clin Biol Res; 1989; 310():237-52. PubMed ID: 2505269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The biology and treatment of superficial bladder cancer.
    Torti FM; Lum BL
    J Clin Oncol; 1984 May; 2(5):505-31. PubMed ID: 6427417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
    Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA
    J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials.
    Sylvester RJ; Oosterlinck W; van der Meijden AP
    J Urol; 2004 Jun; 171(6 Pt 1):2186-90, quiz 2435. PubMed ID: 15126782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study of adriamycin and thiotepa in the chemoprophylaxis of superficial bladder tumors].
    Salinas Sánchez AS; Moreno Avilés J; Pérez Albacete M; Salmerón Lopez-Rua J; Guardiola Más A; Server Falgas G
    Actas Urol Esp; 1989; 13(2):99-102. PubMed ID: 2499166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoprophylaxis with Calmette-Guérin bacillus in recurrent superficial bladder tumors.
    Llopis B; Vera-Donoso CD; Gallego J; Boronat F; Jiménez-Cruz JF
    Eur Urol; 1989; 16(1):28-30. PubMed ID: 2714314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BCG in the management of superficial bladder cancer.
    Guinan P; Richardson C; Hanna M; Rubenstein M
    Prog Clin Biol Res; 1989; 303():447-53. PubMed ID: 2675002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.